SciBase Q2’21: Initial take - Redeye

Redeye's first comments on Scibase's Q2 report. The sales were slightly lower than expected; however, the sales levels are still small, and we are encouraged by the increased levels of electrode sales. Costs were somewhat higher than expected. A higher license fee for ASIC development and increased activity levels in the US is behind this. We will make minor revisions based on the report and do not expect the motived value to change materially.

Länk till analysen i sin helhet: https://www.redeye.se/research/818930/scibase-q221-initial-take?utm_source=finwire&utm_medium=RSS